Med-tech firms raising money in public or private financings, including: 1Life Healthcare, Itamar Medical, Medx Health, Microbix Biosystems, Nephros.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbvie, Alnylam, Bayer, Daiichi Sankyo, Emergent Biosolutions, Lilly, Novo Nordisk, Pfizer, Seattle Genetics.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Aspen, Curevac, Follicum, Fuzionaire, ICER, Nanoviricides, Novartis, Predictive Oncology, Quantitative Medicine, Saromics, Vaxart, Ziopharm.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Kyowa Kirin, Rani, Ziopharm.

Biopharmas raising money in public or private financings, including: Annovis, Arcutis, Concert, Intec, Kezar, Syndax.

Quarterly snapshots from biopharma companies with marketed products, including: Amgen.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Genetesis, Profusa, Righteye, Venturemed

Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Abbott, Bionik, Medtronic, Sony

New hires and promotions in the med-tech industry, including: Collagen Matrix, Generex Biotechnology, Medin Technologies

Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcam, Applied Stemcell, Best Medical International, Bgi, Biofourmis, Conmed, Curetis, Fuzionaire Diagnostics, Healthfirst, Hollister, ImagineMIC, Microsoft, Nationshearing, Transenterix